Trial Profile
A study of effects of high- and low-fat meals on the pharmacokinetics of ozanimod in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Nov 2016
Price :
$35
*
At a glance
- Drugs Ozanimod (Primary)
- Indications Multiple sclerosis; Ulcerative colitis
- Focus Pharmacokinetics
- 12 Nov 2016 New trial record
- 17 Sep 2016 Results presented at the 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis